Stocklytics Platform
Asset logo for symbol BIOL
Biolase
BIOL55
$0.06arrow_drop_down5.57%-$0.00
Penny Stock
Asset logo for symbol BIOL
BIOL55

$0.06

arrow_drop_down5.57%

Performance History

Chart placeholder
Key Stats
Open$0.07
Prev. Close$0.08
EPS-11.97
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$2.50M
PE Ratio-
LOWHIGH
Day Range0.06
0.07
52 Week Range0.04
9.35
Ratios
Revenue-
EPS-11.97

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$804.62
Perf. (24h)
arrow_drop_down2.01%-$16.57
Market Cap$738.87B
Price$569.71
Perf. (24h)
arrow_drop_up1.79%$10.03
Market Cap$527.83B
Price$160.64
Perf. (24h)
arrow_drop_up0.62%$1.00
Market Cap$382.01B
Price$185.16
Perf. (24h)
arrow_drop_up1.64%$2.99
Market Cap$326.96B

About Biolase (BIOL)

Biolase Inc (BIOL) is a medical device company that specializes in laser systems for dental and other medical applications. The company's flagship product is the Waterlase system, which uses water-energized laser technology to perform a wide range of dental procedures with less pain and faster healing times. The Waterlase system has been widely adopted by dental professionals worldwide and has received numerous awards for its innovative design and clinical effectiveness. In addition to its dental products, Biolase also offers laser systems for medical and aesthetic applications, such as skin rejuvenation and hair removal.
Biolase Inc has a market cap of $XX billion and is listed on the Nasdaq exchange under the ticker symbol BIOL. The company's stock price has experienced significant volatility in recent years, with highs and lows influenced by factors such as financial performance, regulatory developments, and industry trends. As of the most recent trading day, Biolase Inc's stock price was $XX, with a 52-week range of $XX to $XX. The stock's average daily trading volume is $XX shares.
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. John R. Beaver
Headquarters
Foothill Ranch
Employees
188
Exchange
NASDAQ
add Biolase  to watchlist

Keep an eye on Biolase

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Biolase 's (BIOL) price per share?
The current price per share for Biolase (BIOL) is $0.07. The stock has seen a price change of -$0 recently, indicating a -5.57% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Biolase (BIOL)?
For Biolase (BIOL), the 52-week high is $9.35, which is 14.05K% from the current price. The 52-week low is $0.04, the current price is 65.25% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Biolase (BIOL) a growth stock?
Biolase (BIOL) has shown an average price growth of 0.41% over the past three years. It has received a score of -6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Biolase as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Biolase (BIOL) stock price performance year to date (YTD)?
As of the latest data, Biolase (BIOL) has a year-to-date price change of -93.99%. Over the past month, the stock has experienced a price change of -11.75%. Over the last three months, the change has been -55.34%. Over the past six months, the figure is -92.21%. Looking at a longer horizon, the five-year price change stands at -100%.
help
Is Biolase (BIOL) a profitable company?
Biolase (BIOL) has a net income of -$20.63M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 34.02% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -44.68% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 1.45%, providing insight into the company's sales performance and growth. The gross profit is $16.72M. Operating income is noted at -$17.94M. Furthermore, the EBITDA is -$13.06M.
help
What is the market capitalization of Biolase (BIOL)?
Biolase (BIOL) has a market capitalization of $2.21M. The average daily trading volume is 125.77K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level